About Us

Archives






Ayala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

Posted: August 15, 2021 at 1:51 am


- Enrolled the First Patient in the Phase 2/3 Pivotal Trial of AL102 for the Treatment of Desmoid Tumors

The rest is here:
Ayala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.